Lisa A. Flanagan, Ph.D.
Lisa A. Flanagan, Ph.D.
Dr. Flanagan received her B.S. in Zoology/Psychology from Duke University and her Ph.D. from the Neuroscience Program at the University of California, San Diego, where she worked in the field of Alzheimer’s disease in the lab of Dr. Tsunao Saitoh. She carried out postdoctoral studies at Brigham and Women’s Hospital and Harvard Medical School in the laboratory of Dr. Paul Janmey and then became an Instructor in Medicine in a program headed by Dr. Thomas Stossel. Dr. Flanagan is currently an Assistant Professor in the Department of Neurology at the University of California, Irvine.
Research in Lay Terms
Dr. Flanagan’s lab is interested in how the neural stem cells that form the brain and spinal cord decide to become one of the three cell types of the central nervous system: neurons, astrocytes, or oligodendrocytes. They hope that understanding this process will lead to greater control over the final differentiated phenotypes of transplanted stem cells.
Neural and embryonic stem cells, neurogenesis, stem cell fate decisions, neuronal cell biology, neuronal regeneration, 3D matrices
Dr. Flanagan’s research program combines the fields of neural cell biology and bioengineering to address issues critical to the successful transplantation of neural stem cells (NSCs) for the repair of injured or diseased central nervous system (CNS) tissue. As such, her lab is investigating factors that affect the differentiation of NSCs into the three CNS lineages (neurons, astrocytes or oligodendrocytes) and exploring means to direct fate decisions of transplanted or endogenous cells for optimal repair and regeneration. Dr. Flanagan’s lab has taken two complementary approaches to these problems. In one, they are developing novel non-invasive methods to identify the fate potential of undifferentiated stem cells with the goal of isolating cells biased to a particular fate. In the other, they investigate the role of extracellular matrix cues in regulating the behavior of NSCs in order to generate instructive three-dimensional matrices for NSC transplantation. Their goal is to achieve greater control over the differentiation of transplanted or endogenous stem cells to unravel the contributions of each cell type to effective repair and potentially maximize their ability to provide functional recovery. These studies have clinical applications for the treatment of spinal cord injury, Alzheimer’s disease, and stroke.
Department of Neurology, School of Medicine
anything by Barbara Kingsolver or Toni Morrison
”You keep using that word. I do not think it means what you think it means.”